Browsing "Comunicações em Eventos - LIM/24" by Title
Showing results 190 to 209 of 577
< previous
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 2016 | The expression profile of biomarkers in squamous cell carcinoma of the anal canal and their influence on treatment outcomes: Preliminary results | MONIZ, Camila Motta Venchiarutti; RIECHELMANN, Rachel Pimenta; RIBEIRO, Suilane Coelho; BARIANI, Giovanni Mendonca; RIVELLI, Thomas Giollo; ORTEGA, Cintia; PEREIRA, Allan Andresson Lima; MEIRELES, Sibele Inacio; CHEN, Andre; NAHAS, Caio, et al |
| 2017 | Extended versus limited pelvic lymphadenectomy during radical prostatectomy for intermediate- and high-risk prostate cancer: Early outcomes from a randomized controlled phase III study. | LESTINGI, Jean Felipe Prodocimo; GUGLIELMETTI, Giuliano; PONTES JR., Jose; MITRE, Anuar Ibrahim; SARKIS, Alvaro; BASTOS, Diogo Assed; RIECHELMANN, Rachel; MATTEDI, Romulo Loss; CORDEIRO, Mauricio; COELHO, Rafael, et al |
| 2018 | Extracellular vesicles and exosome-associated microRNAs in squamous cell carcinoma of the head and neck disrupt dendritic cell differentiation and maturation | MARTI, Luciana C.; SILVA, Elisangela P.; RIZZO, Mariana B.; LOPEZ, Rossana V.; CURIONI, Otavio A.; MOYSES, Raquel A.; NUNES, Fabio D.; SEVERINO, Patricia |
| 2017 | Factors associated with better overall survival (OS) in patients with previously treated, PD-L1-expressing, advanced NSCLC: Multivariate analysis of KEYNOTE-010. | HERBST, Roy S.; BAAS, Paul; KIM, Dong-Wan; FELIP, Enriqueta; PEREZ-GRACIA, Jose Luis; HAN, Ji-Youn; MOLINA, Julian R.; KIM, Joo-Hang; DUBOS, Catherine; AHN, Arvis Myung-Ju, et al |
| 2012 | Feasibility of two schedules of weekly paclitaxel as (neo)adjuvant treatment for patients (PTS) with HER2-negative breast cancer (BC) in the Brazilian community setting | SANTANA, Iuri Amorim; OLIVEIRA, Julia Andrade De; AMARAL, Alan Alves; TESTA, Laura; LANDEIRO, Luciana Garcia; COSTA, Romulo Leopoldo de Paula; HAJIME, Marcelo; FERRARI, Marcela Simonis Martins; PETRY, Vanessa; COHN, Daniela J. B. Heinemann, et al |
| 2014 | Febrile neutropenia risk with adjuvant TC (docetaxel and cyclophosphamide) regimen: Experience of Brazilian cancer centers | SANTOS, Joao Paulo Velloso Medrado; GAGLIATO, Debora De Melo; COSSETTI, Rachel Jorge Dino; GIMENEZ, Rodrigo Darouche; MANO, Max S. |
| 2012 | Fibroblast transcriptome sequencing reveals different gene expression profiles among distinct subtypes of breast cancer and normal mammary tissue | BROMBERG, Natalia; FERREIRA, Elisa Napolitano; MOLINA, Gustavo Campos; PUGA, Renato David; CARRARO, Dirce Maria; BRENTANI, Maria Mitzi |
| 2012 | Fibrogenesis failure of type V collagen observed in pulmonary and cutaneous fibroblast culture reinforce the pathogenic participation of this collagen in the pathway of systemic sclerosis | TEODORO, W. R.; MORAIS, J.; MARTIN, P.; VELOSA, A. P. P.; CARRASCO, S.; SOUZA, R. B. C.; KATAYAMA, M. L.; GOLDEINSTEIN-SCHAINBERG, C.; PARRA, E. R.; CAPELOZZI, V. L., et al |
| 2019 | Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1-positive locally advanced/metastatic NSCLC | MOK, T. S. K.; WU, Y-L.; KUDABA, I.; KOWALSKI, D. M.; CHO, B. C.; TURNA, H. Z.; CASTRO JR., G. de; SRIMUNINNIMIT, V.; LAKTIONOV, K. K.; BONDARENKO, I., et al |
| 2020 | Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation. | POVEDA, Andres; FLOQUET, Anne; LEDERMANN, Jonathan A.; ASHER, Rebecca; PENSON, Richard T.; OZA, Amit M.; KORACH, Jacob; HUZARSKI, Tomasz; PIGNATA, Sandro; FRIEDLANDER, Michael, et al |
| 2021 | Final results of CA209-9JC: A phase II study of first-line nivolumab in patients with advanced cutaneous squamous cell carcinoma | MUNHOZ, R. Ramella; CAMARGO, V. P. de; MARTA, G. Nader; QUEIROZ, M. M.; CURY-MARTINS, J.; NARDO, M.; CHAUL-BARBOSA, C.; RICCI, H.; MATTOS, M. R. de; MENEZES, T. A. F. de, et al |
| 2021 | First-line (1L) maintenance therapy with niraparib (nira) plus pembrolizumab (pembro) vs placebo plus pembro in advanced/metastatic non-small cell lung cancer (NSCLC): Phase 3 ZEAL-1L study | NAGRIAL, Adnan; RAMALINGAM, Suresh S.; CASTRO JR., Gilberto de; GARASSINO, Marina Chiara; MAZIERES, Julien; SANBORN, Rachel; SMIT, Egbert; SPIGEL, David R.; THOMAS, Michael; VELCHETI, Vamsidhar, et al |
| 2021 | First-line (1L) maintenance therapy with niraparib (nira) plus pembrolizumab (pembro) vs placebo plus pembro in advanced/metastatic non-small cell lung cancer (NSCLC): Phase III ZEAL-1L study | RAMALINGAM, S. S.; CASTRO JR., G. de; GARASSINO, M. C. C.; MAZIERES, J.; SANBORN, R. E.; SMIT, E. F. F.; SPIGEL, D. R.; THOMAS, M.; VELCHETI, V.; ZHI, E., et al |
| 2017 | First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK plus ) NSCLC: A Randomized, Phase 3 Study (ASCEND-4) | CASTRO JR., Gilberto De; TAN, Daniel Shao-Weng; CRINO, Lucio; WU, Yi Long; PAZ-ARES, Luis; WOLF, Juergen; GEATER, Sarayut; ORLOV, Sergey; CORTINOVIS, Diego; YU, Chong-Jen, et al |
| 2015 | first-line cisplatin and irinotecan in advanced or metastatic gastric cancer | CHENG, T. Y.; CORREA, T. Strava; ANDRADE, A. Maria Guimaraes M. C.; MUNIZ, D. Queiroz Borges; MESQUITA, M. Coelho; PEREIRA, G. Luiz Stelko; RIECHELMANN, R. Pimenta; HOFF, P. Marcelo Ghem |
| 2017 | First-Line Durvalumab plus Tremelimumab vs Platinum-Based Chemotherapy for Advanced/Metastatic NSCLC: Phase 3 NEPTUNE Study | MOK, Tony; SCHMID, Peter; CASTRO JR., Gilberto De; SYRIGOS, Kostas; MARTIN, Claudio; YAMAMOTO, Nobuyuki; AREN, Osvaldo; ARRIETA, Oscar; GOTTFRIED, Maya; JAZIEH, Abdul Rahman, et al |
| 2023 | Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results | LIU, S. V.; DZIADZIUSZKO, R.; SUGAWARA, S.; KAO, S.; HOCHMAIR, M.; HUEMER, F.; CASTRO JR., G.; HAVEL, L.; CARO, R. B.; LOSONCZY, G., et al |
| 2019 | FLABRA, frontline approach for BRCA testing in ovarian cancer (OC) treatment na ve population: A Latin America (LA) epidemiologic study. | GONCALVES, Susana Beatriz; GIORNELLI, Gonzalo; PEREIRA, Marcelo Horacio; GALLARDO-RINCON, Dolores; ESTEVEZ-DIZ, Maria Del Pilar |
| 2017 | FLABRA, FRONTLINE APPROACH FOR BRCA TESTING IN OVARIAN CANCER (OC) TREATMENT NAIVE POPULATION. A LATIN AMERICA (LA) EPIDEMIOLOGIC STUDY | GONCALVES, S.; GIORNELLI, G.; DIZ, M. D. P. Estevez; GALLARDO, D.; KAEN, D. L.; HOYOS, E.; PHILCO, M.; VEGA, M. De la; ABUIN, G. Gomez; JARAMILLO, L. M., et al |
| 2019 | FLABRA, FRONTLINE APPROACH FOR BRCA TESTING IN OVARIAN CANCER (OC) TREATMENT NAIVE POPULATION. A LATIN AMERICA (LA) EPIDEMIOLOGIC STUDY | GONCALVES, S.; ABUIN, G. Gomez; GALLARDO, D.; DIZ, P. Estevez; CACERES, V.; VEGA, M. De la; PALAZZO, F.; LERZO, G.; KAEN, D.; GERSON, R., et al |